An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis

S. Lekamwasam, J. D. Adachi, D. Agnusdei, J. Bilezikian, S. Boonen, F. Borgström, C. Cooper, A. Diez Perez, R. Eastell, L. C. Hofbauer, J. A. Kanis, B. L. Langdahl, O. Lesnyak, R. Lorenc, E. McCloskey, O. D. Messina, N. Napoli, B. Obermayer-Pietsch, S. H. Ralston, P. N. SambrookS. Silverman, M. Sosa, J. Stepan, G. Suppan, D. A. Wahl, J. E. Compston

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss and increased risk of fragility fracture. Updated clinical guidelines are needed that accommodate recent advances in fracture risk assessment and new pharmacological interventions to reduce fracture risk. This document serves as an appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.

Original languageEnglish
Pages (from-to)25-30
Number of pages6
JournalArchives of Osteoporosis
Volume7
Issue number1-2
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Glucocorticoids
Osteoporosis
Guidelines
Pharmacology
Bone and Bones

Keywords

  • Bone mineral density
  • Bone protective therapy
  • Fracture
  • FRAX
  • Glucocorticoids

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Lekamwasam, S., Adachi, J. D., Agnusdei, D., Bilezikian, J., Boonen, S., Borgström, F., ... Compston, J. E. (2012). An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis. Archives of Osteoporosis, 7(1-2), 25-30. https://doi.org/10.1007/s11657-012-0070-7

An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis. / Lekamwasam, S.; Adachi, J. D.; Agnusdei, D.; Bilezikian, J.; Boonen, S.; Borgström, F.; Cooper, C.; Perez, A. Diez; Eastell, R.; Hofbauer, L. C.; Kanis, J. A.; Langdahl, B. L.; Lesnyak, O.; Lorenc, R.; McCloskey, E.; Messina, O. D.; Napoli, N.; Obermayer-Pietsch, B.; Ralston, S. H.; Sambrook, P. N.; Silverman, S.; Sosa, M.; Stepan, J.; Suppan, G.; Wahl, D. A.; Compston, J. E.

In: Archives of Osteoporosis, Vol. 7, No. 1-2, 12.2012, p. 25-30.

Research output: Contribution to journalArticle

Lekamwasam, S, Adachi, JD, Agnusdei, D, Bilezikian, J, Boonen, S, Borgström, F, Cooper, C, Perez, AD, Eastell, R, Hofbauer, LC, Kanis, JA, Langdahl, BL, Lesnyak, O, Lorenc, R, McCloskey, E, Messina, OD, Napoli, N, Obermayer-Pietsch, B, Ralston, SH, Sambrook, PN, Silverman, S, Sosa, M, Stepan, J, Suppan, G, Wahl, DA & Compston, JE 2012, 'An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis', Archives of Osteoporosis, vol. 7, no. 1-2, pp. 25-30. https://doi.org/10.1007/s11657-012-0070-7
Lekamwasam, S. ; Adachi, J. D. ; Agnusdei, D. ; Bilezikian, J. ; Boonen, S. ; Borgström, F. ; Cooper, C. ; Perez, A. Diez ; Eastell, R. ; Hofbauer, L. C. ; Kanis, J. A. ; Langdahl, B. L. ; Lesnyak, O. ; Lorenc, R. ; McCloskey, E. ; Messina, O. D. ; Napoli, N. ; Obermayer-Pietsch, B. ; Ralston, S. H. ; Sambrook, P. N. ; Silverman, S. ; Sosa, M. ; Stepan, J. ; Suppan, G. ; Wahl, D. A. ; Compston, J. E. / An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis. In: Archives of Osteoporosis. 2012 ; Vol. 7, No. 1-2. pp. 25-30.
@article{4f734cdce32548128ee602a01f7f97b4,
title = "An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis",
abstract = "The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss and increased risk of fragility fracture. Updated clinical guidelines are needed that accommodate recent advances in fracture risk assessment and new pharmacological interventions to reduce fracture risk. This document serves as an appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.",
keywords = "Bone mineral density, Bone protective therapy, Fracture, FRAX, Glucocorticoids",
author = "S. Lekamwasam and Adachi, {J. D.} and D. Agnusdei and J. Bilezikian and S. Boonen and F. Borgstr{\"o}m and C. Cooper and Perez, {A. Diez} and R. Eastell and Hofbauer, {L. C.} and Kanis, {J. A.} and Langdahl, {B. L.} and O. Lesnyak and R. Lorenc and E. McCloskey and Messina, {O. D.} and N. Napoli and B. Obermayer-Pietsch and Ralston, {S. H.} and Sambrook, {P. N.} and S. Silverman and M. Sosa and J. Stepan and G. Suppan and Wahl, {D. A.} and Compston, {J. E.}",
year = "2012",
month = "12",
doi = "10.1007/s11657-012-0070-7",
language = "English",
volume = "7",
pages = "25--30",
journal = "Archives of Osteoporosis",
issn = "1862-3522",
publisher = "Springer London",
number = "1-2",

}

TY - JOUR

T1 - An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis

AU - Lekamwasam, S.

AU - Adachi, J. D.

AU - Agnusdei, D.

AU - Bilezikian, J.

AU - Boonen, S.

AU - Borgström, F.

AU - Cooper, C.

AU - Perez, A. Diez

AU - Eastell, R.

AU - Hofbauer, L. C.

AU - Kanis, J. A.

AU - Langdahl, B. L.

AU - Lesnyak, O.

AU - Lorenc, R.

AU - McCloskey, E.

AU - Messina, O. D.

AU - Napoli, N.

AU - Obermayer-Pietsch, B.

AU - Ralston, S. H.

AU - Sambrook, P. N.

AU - Silverman, S.

AU - Sosa, M.

AU - Stepan, J.

AU - Suppan, G.

AU - Wahl, D. A.

AU - Compston, J. E.

PY - 2012/12

Y1 - 2012/12

N2 - The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss and increased risk of fragility fracture. Updated clinical guidelines are needed that accommodate recent advances in fracture risk assessment and new pharmacological interventions to reduce fracture risk. This document serves as an appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.

AB - The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss and increased risk of fragility fracture. Updated clinical guidelines are needed that accommodate recent advances in fracture risk assessment and new pharmacological interventions to reduce fracture risk. This document serves as an appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.

KW - Bone mineral density

KW - Bone protective therapy

KW - Fracture

KW - FRAX

KW - Glucocorticoids

UR - http://www.scopus.com/inward/record.url?scp=84876297687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876297687&partnerID=8YFLogxK

U2 - 10.1007/s11657-012-0070-7

DO - 10.1007/s11657-012-0070-7

M3 - Article

C2 - 23225278

AN - SCOPUS:84876297687

VL - 7

SP - 25

EP - 30

JO - Archives of Osteoporosis

JF - Archives of Osteoporosis

SN - 1862-3522

IS - 1-2

ER -